Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$56.6 - $89.9 $472,666 - $750,754
8,351 Added 66.88%
20,838 $1.45 Million
Q4 2021

Jan 31, 2022

BUY
$75.08 - $121.99 $195,283 - $317,295
2,601 Added 26.31%
12,487 $938,000
Q2 2021

Aug 04, 2021

SELL
$130.4 - $225.58 $294,443 - $509,359
-2,258 Reduced 18.59%
9,886 $2.19 Million
Q4 2020

Feb 09, 2021

BUY
$112.16 - $174.14 $638,975 - $992,075
5,697 Added 88.37%
12,144 $2.1 Million
Q3 2020

Nov 03, 2020

BUY
$58.05 - $111.31 $374,248 - $717,615
6,447 New
6,447 $718,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.68B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Illinois Municipal Retirement Fund Portfolio

Follow Illinois Municipal Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Illinois Municipal Retirement Fund with notifications on news.